Evotec EVO achieved substantial progress in its strategic partnership with Bristol Myers Squibb BMY relating to building a ...

Pfizer and BioNTech said Friday that their combined mRNA vaccine candidate against influenza and Covid-19 showed a lower immune response against one type of influenza, influenza B, in a Phase 3 ...

Just a couple of years ago, Pfizer's (PFE 0.45%) revenue was soaring thanks to sales of its coronavirus vaccine. In fact, the vaccine became the world's best-selling pharmaceutical product and ...

BOTHELL, Wash.—At a recent company town hall here, Pfizer’s cancer-business chief looked over some 100 scientists, marketers and other staffers who had just joined the giant drugmaker through ...

Pfizer beat pharma records when its annual revenue soared past $100 billion in 2022, thanks to its coronavirus vaccine and treatment. As demand for these products slowed, revenue dropped -- so the ...

Pfizer CEO on Moving Beyond COVID Vaccines to Become a Leader in Cancer and Obesity Treatments WASHINGTON (AP) — Two years ago, Pfizer was the envy of the pharmaceutical world, with more than $ ...

Despite Wall Street's continued conservatism regarding its business prospects, Pfizer beat analysts' expectations for the second quarter of 2024. In addition to the raised full-year 2024 guidance ...

Pfizer Inc.’s stock rose 1% Tuesday after the company blew past earnings estimates for the second quarter, offered an update on a cost-cutting plan and raised its revenue and profit guidance for ...

July 30 (Reuters) - Pfizer (PFE.N), opens new tab raised its annual profit forecast on Tuesday, helped by cancer treatments acquired through a $43 billion deal for Seagen and strong sales of its ...

1 Day PFE -0.98% DJIA -0.48% S&P 500 -0.92% Health Care/Life Sciences 0.02% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Last month, Evotec entered into a multi-year collaboration deal with Pfizer PFE. Per the deal terms, this partnership with Pfizer will focus on early discovery research for metabolic and ...